Positive association between MTHFR C677T polymorphism and oral cancer risk: a meta-analysis

Blot WJ et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988;48(11):3282–7.

Hayes RB et al. Tobacco and alcohol use and oral cancer in Puerto Rico. Cancer Causes Control. 1999;10(1):27–33.

Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45(4–5):309–16.

Glade MJ. Food, nutrition, and the prevention of cancer: a global perspective. Nutrition. 1999;15(6):523–6. American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997.

Choi SW, Mason JB. Folate and carcinogenesis: an integrated scheme. J Nutr. 2000;130(2):129–32.

Giovannucci E et al. Alcohol, low-methionine–low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst. 1995;87(4):265–73.

Jaskiewicz K et al. Association of esophageal cytological abnormalities with vitamin and lipotrope deficiencies in populations at risk for esophageal cancer. Anticancer Res. 1988;8(4):711–5.

Tseng M et al. Micronutrients and the risk of colorectal adenomas. Am J Epidemiol. 1996;144(11):1005–14.

Blount BC et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A. 1997;94(7):3290–5.

Kingsley K et al. Analysis of oral cancer epidemiology in the US reveals state-specific trends: implications for oral cancer prevention. BMC Public Health. 2008;8:87.

Marney AM et al. Endogenous bradykinin contributes to increased plasminogen activator inhibitor 1 antigen following hemodialysis. J Am Soc Nephrol. 2009;20(10):2246–52.

Masuda J, Nabika T, Notsu Y. Silent stroke: pathogenesis, genetic factors and clinical implications as a risk factor. Curr Opin Neurol. 2001;14(1):77–82.

Frosst P et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10(1):111–3.

Zetterberg H et al. Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos. Eur J Hum Genet. 2002;10(2):113–8.

Kim RJ, Becker RC. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J. 2003;146(6):948–57.

Galbiatti AL et al. Head and neck cancer: genetic polymorphisms and folate metabolism. Braz J Otorhinolaryngol. 2012;78(1):132–9.

Lee JE et al. Plasma folate, methylenetetrahydrofolate reductase (MTHFR), and colorectal cancer risk in three large nested case–control studies. Cancer Causes Control. 2012;23(4):537–45.

Kiyohara C et al. Methylenetetrahydrofolate reductase polymorphisms and interaction with smoking and alcohol consumption in lung cancer risk: a case–control study in a Japanese population. BMC Cancer. 2011;11:459.

Gao CM et al. [MTHFR polymorphisms, dietary folate intake and risks to breast cancer]. Zhonghua Yu Fang Yi Xue Za Zhi. 2009;43(7):576–80.

Weinstein SJ et al. Folate intake, serum homocysteine and methylenetetrahydrofolate reductase (MTHFR) C677T genotype are not associated with oral cancer risk in Puerto Rico. J Nutr. 2002;132(4):762–7.

Solomon PR, Selvam GS, Shanmugam G. Polymorphism in ADH and MTHFR genes in oral squamous cell carcinoma of Indians. Oral Dis. 2008;14(7):633–9.

Higgins JP et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.

DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.

Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–48.

Egger M et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.

Liao, G., et al., Host genetic susceptibility to oral cancer: evidence from meta-analyses and pooled analyses. Oral Dis, 2013

Vairaktaris E et al. Methylenetetrahydrofolate reductase polymorphism and minor increase of risk for oral cancer. J Cancer Res Clin Oncol. 2006;132(4):219–22.

Tsai CW et al. Methylenetetrahydrofolate reductase (MTHFR) genotype, smoking habit, metastasis and oral cancer in Taiwan. Anticancer Res. 2011;31(6):2395–9.

Supic G, Jovic N, Kozomara R, Zeljic K, Magic Z. Interaction between the MTHFR C677T polymorphism and alcohol—impact on oral cancer risk and multiple DNA methylation of tumor-related genes. J Dent Res. 2011;90(1):65–70.

Sailasree R et al. Influence of methylenetetrahydrofolate reductase polymorphisms in oral cancer patients. J Oral Pathol Med. 2011;40(1):61–6.

Galbiatti AL et al. Polymorphisms and haplotypes in methylenetetrahydrofolate reductase gene and head and neck squamous cell carcinoma risk. Mol Biol Rep. 2012;39(1):635–43.

Vylliotis A et al. Effect of thrombosis-related gene polymorphisms upon oral cancer: a regression analysis. Anticancer Res. 2013;33(9):4033–9.

Duthie SJ et al. Folate, DNA stability and colo-rectal neoplasia. Proc Nutr Soc. 2004;63(4):571–8.

Rozen R. Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb Haemost. 1997;78(1):523–6.

Zhuo X et al. Polymorphisms of MTHFR C677T and A1298C association with oral carcinoma risk: a meta-analysis. Cancer Invest. 2012;30(6):447–52.

Suzuki T, Matsuo K, Hasegawa Y, Hiraki A, Wakai K, Hirose K, et al. One-carbon metabolism-related gene polymorphisms and risk of head and neck squamous cell carcinoma: case–control study. Cancer Sci. 2007;98:1439–46.